Role of STAT6 in IgE receptor/FcεRI-mediated late phase allergic responses of mast cells

Journal of Immunology

Volumn 168, Issue 1, 2002, Pages 421-426

  Malaviya, R ^a   Uckun, F M ^a  

^a PARKER HUGHES INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FC RECEPTOR; HISTAMINE; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 6; LEUKOTRIENE C4; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CONTROLLED STUDY; ESCHERICHIA COLI; HISTAMINE RELEASE; MALE; MAST CELL; MOUSE; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PRIORITY JOURNAL;

EID: 0036134845     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.1.421     Document Type: Article

References (43)

1. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease
2. The high-affinity receptor for IgE
3. The high affinity IgE receptor (FcεRI): From physiology to pathology
4. Ionophore A-23187 induced histamine release from rat mast cells and rat basophil leukemia (RBL-1) cells
5. Early events in mast cell signal transduction
6. Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells
7. Functions of Bruton's tyrosine kinase in mast and B cells
8. Terreic acid, a quinone epoxide inhibitor of Bruton's tyrosine kinase
9. Janus kinases in cytokine signalling
10. Duration of STAT5 activation influences the response of interleukin-2 receptor alpha gene to different cytokines
11. Jaks and Stats in cytokine signaling
12. Targeting Janus kinase 3 in mast cells prevents immediate hypersensitivity reactions and anaphylaxis
13. Treatment of allergic asthma by targeting janus kinase 3-dependent leukotriene synthesis in mast cells with 4-(3′,5′-dibromo-4′-hydroxyphenyl)amino-6,7- dimethoxyquinazoline (WHI-P97)
14. Genetic and biochemical evidence for a critical role of Janus kinase (JAK)-3 in mast cell-mediated type I hypersensitivity reactions
15. An update on interleukin-4 and its receptor
16. IL-4 preferentially activates a novel STAT6 isoform in mast cells
17. c)- and Jak3-dependent signaling in the proliferation and survival of murine mast-cells
18. IL-4 inhibits mouse mast cell FeεRI expression through a STAT6-dependent mechanism
19. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene
20. Contribution of macrophages to immediate hypersensitivity reaction
21. Monoclonal dinitrophenylspecific murine IgE antibody: Preparation, isolation, and characterization
22. Mast cell phagocytosis of FimH-expressing enterobacteria
23. Mast cell degranulation induced by type 1 fimbriated Escherichia coli in mice
24. Interaction of bacteria with mast cells
25. Clinical implications of mast cell-bacteria interaction
26. Large scale isolation of intact rat basophilic leukemia (RBL-2H3) cells
27. BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells
28. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases
29. Histamine in human epidermal cells is induced by ultraviolet light injury
30. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FcγRIII: Assessment of cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis
31. Role of mast cells in the onset of IgE-mediated late-phase cutaneous response in mice
32. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48
33. Mast cell mediators regulate vascular permeability changes in arthus reaction
34. Augmentation of reverse arthus reaction by mast cells in mice
35. Involvement of Bruton's tyrosine kinase in FcεRI-dependent mast cell degranulatioa and cytokine production
36. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent: Partial inhibition of the reaction with antiserum against tumor necrosis factor-α
37. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells
38. Essential role of Stat6 in IL-4 signalling
39. The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5
40. + T cells
41. Variants of STAT6 (signal transducer and activator of transcription 6) in atopic asthma
42. An immunopharmacological study of the biphasic allergic skin reaction in mice
43. IL-4 inhibits the production of TNF-α and IL-12 by STAT6-dependent and -independent mechanisms